Market Overview

After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, THOR Lower

Related BV
Credit Suisse Sees First Green Signs Of Recovery For Bazaarvoice Inc
Morgan Stanley Is Encouraged By Positive Trends At Bazaarvoice Inc
Related SWHC
5 Stocks To Watch During Hunting Season
Bear of the Day: Smith & Wesson (SWHC) - Bear of the Day
Making Money With Charles Payne: 08/29/14 (Fox Business)

Moving up:

  • Bazaarvoice (NASDAQ: BV) - up 8% - Reports Q3 EPS of $(0.04) vs $(0.06) est; revenue of $48.0M vs $46.57M est.
  • Smith & Wesson (NASDAQ: SWHC) - up 6% - Reports Q3 EPS of $0.36 vs $0.29 Est; Revenue of $145.90M vs $142.70M Est. Looking for Q4 EPS of $0.37-0.40 vs $0.35 analyst estimate. Sees sales of $159.0M-164.0M vs $165.0M estimate, FY2014 EPS of $1.39-1.42 vs $1.33 analyst estimate. Sees sales of $615.0M-620.0M vs $618.0M estimate.
  • AeroVironment (NASDAQ: AVAV) - up 5.5% - Reports Q3 EPS of $0.49 vs $0.19 est; revenue of $69.20M vs $64.96M est. Sees FY2014 EPS $0.35-0.50; sees sales $230.0M-250.0M.
  • Cell Therapeutics (NASDAQ: CTIC) - up 3.5% - Reports Q4 EPS of $0.08 which may not compare $(0.16) est.
  • Arrowhead Research (NASDAQ: ARWR) - up 3.5% - Momentum continuing after recieving regulatory approval to being phase 2a trial of Chronic Hepatitis B candidate ARC-520 on Monday. After the close, RBC initiated coverage on the stock with an Outperform rating and $35 price target.

Moving down:

  • Homeowners Choice (NYSE: HCI) reports Q4 EPS of $1.31 versus the estimated $1.45, missing by $0.14.
  • Bob Evans Farms, Inc. (NASDAQ: BOBE) reports Q3 EPS of $0.30 versus the estimated $0.57, missing by $0.27. Sees FY2014 EPS of $1.60-1.75 vs $2.26 analyst estimate, FY2015 EPS of $2.80-3.00 vs $2.90 analyst estimate. Announced a $100M buyback plan.
  • Chef's Warehouse (NASDAQ: CHEF) - down 5.5% - Reports Q4 EPS of $0.19 vs $0.20 est; revenue of $193.40M vs $191.27M est.
  • Thoratec (NASDAQ: THOR) Issues Global Urgent Medical Device Correction, Will Update Labeling on Use of Heartmate II LVAS, Says Difficulties Have Resulted in Four Deaths
  • ABM Industries Incorporated (NYSE: ABM) reports Q1 EPS of $0.25 versus the estimated $0.25, inline. EPS were Down 4% from the same quarter last year. Revenue came in at $1.23B versus the estimated $1.24B. Sales were Up 4% year over year.
  • Merrimack Pharma (NASDAQ: MACK) - down 1.45% - Files mixed securities shelf up to $200M.
  • BankUnited (NYSE: BKU) - down 1.5% - Announces secondary offering of common stock.

Posted-In: News Movers

 

Related Articles (ARWR + ABM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters